BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1235 related articles for article (PubMed ID: 32324595)

  • 1. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological features of severe and moderate coronavirus disease 2019.
    Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
    J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal SARS-CoV-2-specific CD8
    Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
    Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
    Mazzoni A; Salvati L; Maggi L; Capone M; Vanni A; Spinicci M; Mencarini J; Caporale R; Peruzzi B; Antonelli A; Trotta M; Zammarchi L; Ciani L; Gori L; Lazzeri C; Matucci A; Vultaggio A; Rossi O; Almerigogna F; Parronchi P; Fontanari P; Lavorini F; Peris A; Rossolini GM; Bartoloni A; Romagnani S; Liotta F; Annunziato F; Cosmi L
    J Clin Invest; 2020 Sep; 130(9):4694-4703. PubMed ID: 32463803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappearance of effector T cells is associated with recovery from COVID-19.
    Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR
    EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Metabolic Changes and Immune Profiles in Patients With COVID-19.
    He B; Wang J; Wang Y; Zhao J; Huang J; Tian Y; Yang C; Zhang H; Zhang M; Gu L; Zhou X; Zhou J
    Front Immunol; 2020; 11():2075. PubMed ID: 32983157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2: a storm is raging.
    Pedersen SF; Ho YC
    J Clin Invest; 2020 May; 130(5):2202-2205. PubMed ID: 32217834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
    Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
    Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.
    Liu B; Han J; Cheng X; Yu L; Zhang L; Wang W; Ni L; Wei C; Huang Y; Cheng Z
    Sci Rep; 2020 Oct; 10(1):17718. PubMed ID: 33077873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
    Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2020; 11():1870. PubMed ID: 32983106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.
    Kang CK; Han GC; Kim M; Kim G; Shin HM; Song KH; Choe PG; Park WB; Kim ES; Kim HB; Kim NJ; Kim HR; Oh MD
    Int J Infect Dis; 2020 Aug; 97():313-321. PubMed ID: 32492530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
    Qiu L; Jiao R; Zhang A; Chen X; Ning Q; Fang F; Zeng F; Tian N; Zhang Y; Huang Y; Sun Z; Dhuromsingh M; Li H; Li Y; Xu R; Chen Y; Luo X
    Pediatr Infect Dis J; 2020 Jul; 39(7):e87-e90. PubMed ID: 32379199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.